Global Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

According to our (Global Info Research) latest study, the global Vaccine Adjuvants market size was valued at US$ 654 million in 2023 and is forecast to a readjusted size of USD 1144 million by 2030 with a CAGR of 8.5% during review period.

The vaccine adjuvants market is driven by the increasing need for more effective and long-lasting vaccines. Adjuvants are substances added to vaccines to enhance the body’s immune response, making vaccines more effective, especially in cases where the antigen alone may not provide sufficient protection. The growing prevalence of infectious diseases and the rising demand for vaccines to address new and emerging pathogens, such as COVID-19 variants, are fueling the development and adoption of advanced adjuvants. Additionally, ongoing research and development in immunology and biotechnology are leading to the creation of novel adjuvants that improve vaccine efficacy and safety.

One of the main challenges in the vaccine adjuvants market is the complexity and cost associated with developing and producing new adjuvants. The process requires significant investment in research and development, as well as rigorous testing to ensure safety and effectiveness. Additionally, there are regulatory hurdles that must be overcome, as new adjuvants need to meet stringent guidelines before they can be approved for use. Public concerns about vaccine safety and the potential for adverse reactions to adjuvants also pose challenges, as any negative perceptions can impact vaccine acceptance and adoption.

This report is a detailed and comprehensive analysis for global Vaccine Adjuvants market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Vaccine Adjuvants market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030
Global Vaccine Adjuvants market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030
Global Vaccine Adjuvants market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030
Global Vaccine Adjuvants market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vaccine Adjuvants
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vaccine Adjuvants market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, CSL Limited, Croda, SEPPIC, Sanofi, Zhifei Biological, Escon, Huanuotai Biological, Rico Bio, SDA BIO, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Vaccine Adjuvants market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Emulsion Adjuvants
    Mineral Adjuvants
    Others

Market segment by Application
    Human Vaccine
    Veterinary Vaccine

Major players covered
    GSK
    CSL Limited
    Croda
    SEPPIC
    Sanofi
    Zhifei Biological
    Escon
    Huanuotai Biological
    Rico Bio
    SDA BIO
    SPI Pharma
    Phibro Animal Health
    Vertellus

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine Adjuvants product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccine Adjuvants, with price, sales quantity, revenue, and global market share of Vaccine Adjuvants from 2019 to 2024.
Chapter 3, the Vaccine Adjuvants competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Vaccine Adjuvants market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccine Adjuvants.
Chapter 14 and 15, to describe Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Vaccine Adjuvants Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Emulsion Adjuvants
        1.3.3 Mineral Adjuvants
        1.3.4 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Vaccine Adjuvants Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Human Vaccine
        1.4.3 Veterinary Vaccine
    1.5 Global Vaccine Adjuvants Market Size & Forecast
        1.5.1 Global Vaccine Adjuvants Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Vaccine Adjuvants Sales Quantity (2019-2030)
        1.5.3 Global Vaccine Adjuvants Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 GSK
        2.1.1 GSK Details
        2.1.2 GSK Major Business
        2.1.3 GSK Vaccine Adjuvants Product and Services
        2.1.4 GSK Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 GSK Recent Developments/Updates
    2.2 CSL Limited
        2.2.1 CSL Limited Details
        2.2.2 CSL Limited Major Business
        2.2.3 CSL Limited Vaccine Adjuvants Product and Services
        2.2.4 CSL Limited Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 CSL Limited Recent Developments/Updates
    2.3 Croda
        2.3.1 Croda Details
        2.3.2 Croda Major Business
        2.3.3 Croda Vaccine Adjuvants Product and Services
        2.3.4 Croda Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Croda Recent Developments/Updates
    2.4 SEPPIC
        2.4.1 SEPPIC Details
        2.4.2 SEPPIC Major Business
        2.4.3 SEPPIC Vaccine Adjuvants Product and Services
        2.4.4 SEPPIC Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 SEPPIC Recent Developments/Updates
    2.5 Sanofi
        2.5.1 Sanofi Details
        2.5.2 Sanofi Major Business
        2.5.3 Sanofi Vaccine Adjuvants Product and Services
        2.5.4 Sanofi Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Sanofi Recent Developments/Updates
    2.6 Zhifei Biological
        2.6.1 Zhifei Biological Details
        2.6.2 Zhifei Biological Major Business
        2.6.3 Zhifei Biological Vaccine Adjuvants Product and Services
        2.6.4 Zhifei Biological Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Zhifei Biological Recent Developments/Updates
    2.7 Escon
        2.7.1 Escon Details
        2.7.2 Escon Major Business
        2.7.3 Escon Vaccine Adjuvants Product and Services
        2.7.4 Escon Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Escon Recent Developments/Updates
    2.8 Huanuotai Biological
        2.8.1 Huanuotai Biological Details
        2.8.2 Huanuotai Biological Major Business
        2.8.3 Huanuotai Biological Vaccine Adjuvants Product and Services
        2.8.4 Huanuotai Biological Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Huanuotai Biological Recent Developments/Updates
    2.9 Rico Bio
        2.9.1 Rico Bio Details
        2.9.2 Rico Bio Major Business
        2.9.3 Rico Bio Vaccine Adjuvants Product and Services
        2.9.4 Rico Bio Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Rico Bio Recent Developments/Updates
    2.10 SDA BIO
        2.10.1 SDA BIO Details
        2.10.2 SDA BIO Major Business
        2.10.3 SDA BIO Vaccine Adjuvants Product and Services
        2.10.4 SDA BIO Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 SDA BIO Recent Developments/Updates
    2.11 SPI Pharma
        2.11.1 SPI Pharma Details
        2.11.2 SPI Pharma Major Business
        2.11.3 SPI Pharma Vaccine Adjuvants Product and Services
        2.11.4 SPI Pharma Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 SPI Pharma Recent Developments/Updates
    2.12 Phibro Animal Health
        2.12.1 Phibro Animal Health Details
        2.12.2 Phibro Animal Health Major Business
        2.12.3 Phibro Animal Health Vaccine Adjuvants Product and Services
        2.12.4 Phibro Animal Health Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Phibro Animal Health Recent Developments/Updates
    2.13 Vertellus
        2.13.1 Vertellus Details
        2.13.2 Vertellus Major Business
        2.13.3 Vertellus Vaccine Adjuvants Product and Services
        2.13.4 Vertellus Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Vertellus Recent Developments/Updates

3 Competitive Environment: Vaccine Adjuvants by Manufacturer
    3.1 Global Vaccine Adjuvants Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Vaccine Adjuvants Revenue by Manufacturer (2019-2024)
    3.3 Global Vaccine Adjuvants Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Vaccine Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Vaccine Adjuvants Manufacturer Market Share in 2023
        3.4.3 Top 6 Vaccine Adjuvants Manufacturer Market Share in 2023
    3.5 Vaccine Adjuvants Market: Overall Company Footprint Analysis
        3.5.1 Vaccine Adjuvants Market: Region Footprint
        3.5.2 Vaccine Adjuvants Market: Company Product Type Footprint
        3.5.3 Vaccine Adjuvants Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Vaccine Adjuvants Market Size by Region
        4.1.1 Global Vaccine Adjuvants Sales Quantity by Region (2019-2030)
        4.1.2 Global Vaccine Adjuvants Consumption Value by Region (2019-2030)
        4.1.3 Global Vaccine Adjuvants Average Price by Region (2019-2030)
    4.2 North America Vaccine Adjuvants Consumption Value (2019-2030)
    4.3 Europe Vaccine Adjuvants Consumption Value (2019-2030)
    4.4 Asia-Pacific Vaccine Adjuvants Consumption Value (2019-2030)
    4.5 South America Vaccine Adjuvants Consumption Value (2019-2030)
    4.6 Middle East & Africa Vaccine Adjuvants Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    5.2 Global Vaccine Adjuvants Consumption Value by Type (2019-2030)
    5.3 Global Vaccine Adjuvants Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    6.2 Global Vaccine Adjuvants Consumption Value by Application (2019-2030)
    6.3 Global Vaccine Adjuvants Average Price by Application (2019-2030)

7 North America
    7.1 North America Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    7.2 North America Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    7.3 North America Vaccine Adjuvants Market Size by Country
        7.3.1 North America Vaccine Adjuvants Sales Quantity by Country (2019-2030)
        7.3.2 North America Vaccine Adjuvants Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    8.2 Europe Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    8.3 Europe Vaccine Adjuvants Market Size by Country
        8.3.1 Europe Vaccine Adjuvants Sales Quantity by Country (2019-2030)
        8.3.2 Europe Vaccine Adjuvants Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Vaccine Adjuvants Market Size by Region
        9.3.1 Asia-Pacific Vaccine Adjuvants Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Vaccine Adjuvants Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    10.2 South America Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    10.3 South America Vaccine Adjuvants Market Size by Country
        10.3.1 South America Vaccine Adjuvants Sales Quantity by Country (2019-2030)
        10.3.2 South America Vaccine Adjuvants Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Vaccine Adjuvants Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Vaccine Adjuvants Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Vaccine Adjuvants Market Size by Country
        11.3.1 Middle East & Africa Vaccine Adjuvants Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Vaccine Adjuvants Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Vaccine Adjuvants Market Drivers
    12.2 Vaccine Adjuvants Market Restraints
    12.3 Vaccine Adjuvants Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Vaccine Adjuvants and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Vaccine Adjuvants
    13.3 Vaccine Adjuvants Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Vaccine Adjuvants Typical Distributors
    14.3 Vaccine Adjuvants Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Vaccine Adjuvants Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Vaccine Adjuvants Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. GSK Basic Information, Manufacturing Base and Competitors
 Table 4. GSK Major Business
 Table 5. GSK Vaccine Adjuvants Product and Services
 Table 6. GSK Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. GSK Recent Developments/Updates
 Table 8. CSL Limited Basic Information, Manufacturing Base and Competitors
 Table 9. CSL Limited Major Business
 Table 10. CSL Limited Vaccine Adjuvants Product and Services
 Table 11. CSL Limited Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. CSL Limited Recent Developments/Updates
 Table 13. Croda Basic Information, Manufacturing Base and Competitors
 Table 14. Croda Major Business
 Table 15. Croda Vaccine Adjuvants Product and Services
 Table 16. Croda Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Croda Recent Developments/Updates
 Table 18. SEPPIC Basic Information, Manufacturing Base and Competitors
 Table 19. SEPPIC Major Business
 Table 20. SEPPIC Vaccine Adjuvants Product and Services
 Table 21. SEPPIC Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. SEPPIC Recent Developments/Updates
 Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 24. Sanofi Major Business
 Table 25. Sanofi Vaccine Adjuvants Product and Services
 Table 26. Sanofi Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Sanofi Recent Developments/Updates
 Table 28. Zhifei Biological Basic Information, Manufacturing Base and Competitors
 Table 29. Zhifei Biological Major Business
 Table 30. Zhifei Biological Vaccine Adjuvants Product and Services
 Table 31. Zhifei Biological Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Zhifei Biological Recent Developments/Updates
 Table 33. Escon Basic Information, Manufacturing Base and Competitors
 Table 34. Escon Major Business
 Table 35. Escon Vaccine Adjuvants Product and Services
 Table 36. Escon Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. Escon Recent Developments/Updates
 Table 38. Huanuotai Biological Basic Information, Manufacturing Base and Competitors
 Table 39. Huanuotai Biological Major Business
 Table 40. Huanuotai Biological Vaccine Adjuvants Product and Services
 Table 41. Huanuotai Biological Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. Huanuotai Biological Recent Developments/Updates
 Table 43. Rico Bio Basic Information, Manufacturing Base and Competitors
 Table 44. Rico Bio Major Business
 Table 45. Rico Bio Vaccine Adjuvants Product and Services
 Table 46. Rico Bio Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 47. Rico Bio Recent Developments/Updates
 Table 48. SDA BIO Basic Information, Manufacturing Base and Competitors
 Table 49. SDA BIO Major Business
 Table 50. SDA BIO Vaccine Adjuvants Product and Services
 Table 51. SDA BIO Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 52. SDA BIO Recent Developments/Updates
 Table 53. SPI Pharma Basic Information, Manufacturing Base and Competitors
 Table 54. SPI Pharma Major Business
 Table 55. SPI Pharma Vaccine Adjuvants Product and Services
 Table 56. SPI Pharma Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 57. SPI Pharma Recent Developments/Updates
 Table 58. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
 Table 59. Phibro Animal Health Major Business
 Table 60. Phibro Animal Health Vaccine Adjuvants Product and Services
 Table 61. Phibro Animal Health Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 62. Phibro Animal Health Recent Developments/Updates
 Table 63. Vertellus Basic Information, Manufacturing Base and Competitors
 Table 64. Vertellus Major Business
 Table 65. Vertellus Vaccine Adjuvants Product and Services
 Table 66. Vertellus Vaccine Adjuvants Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 67. Vertellus Recent Developments/Updates
 Table 68. Global Vaccine Adjuvants Sales Quantity by Manufacturer (2019-2024) & (MT)
 Table 69. Global Vaccine Adjuvants Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 70. Global Vaccine Adjuvants Average Price by Manufacturer (2019-2024) & (USD/Kg)
 Table 71. Market Position of Manufacturers in Vaccine Adjuvants, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 72. Head Office and Vaccine Adjuvants Production Site of Key Manufacturer
 Table 73. Vaccine Adjuvants Market: Company Product Type Footprint
 Table 74. Vaccine Adjuvants Market: Company Product Application Footprint
 Table 75. Vaccine Adjuvants New Market Entrants and Barriers to Market Entry
 Table 76. Vaccine Adjuvants Mergers, Acquisition, Agreements, and Collaborations
 Table 77. Global Vaccine Adjuvants Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 78. Global Vaccine Adjuvants Sales Quantity by Region (2019-2024) & (MT)
 Table 79. Global Vaccine Adjuvants Sales Quantity by Region (2025-2030) & (MT)
 Table 80. Global Vaccine Adjuvants Consumption Value by Region (2019-2024) & (USD Million)
 Table 81. Global Vaccine Adjuvants Consumption Value by Region (2025-2030) & (USD Million)
 Table 82. Global Vaccine Adjuvants Average Price by Region (2019-2024) & (USD/Kg)
 Table 83. Global Vaccine Adjuvants Average Price by Region (2025-2030) & (USD/Kg)
 Table 84. Global Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (MT)
 Table 85. Global Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (MT)
 Table 86. Global Vaccine Adjuvants Consumption Value by Type (2019-2024) & (USD Million)
 Table 87. Global Vaccine Adjuvants Consumption Value by Type (2025-2030) & (USD Million)
 Table 88. Global Vaccine Adjuvants Average Price by Type (2019-2024) & (USD/Kg)
 Table 89. Global Vaccine Adjuvants Average Price by Type (2025-2030) & (USD/Kg)
 Table 90. Global Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (MT)
 Table 91. Global Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (MT)
 Table 92. Global Vaccine Adjuvants Consumption Value by Application (2019-2024) & (USD Million)
 Table 93. Global Vaccine Adjuvants Consumption Value by Application (2025-2030) & (USD Million)
 Table 94. Global Vaccine Adjuvants Average Price by Application (2019-2024) & (USD/Kg)
 Table 95. Global Vaccine Adjuvants Average Price by Application (2025-2030) & (USD/Kg)
 Table 96. North America Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (MT)
 Table 97. North America Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (MT)
 Table 98. North America Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (MT)
 Table 99. North America Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (MT)
 Table 100. North America Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (MT)
 Table 101. North America Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (MT)
 Table 102. North America Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
 Table 103. North America Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
 Table 104. Europe Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (MT)
 Table 105. Europe Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (MT)
 Table 106. Europe Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (MT)
 Table 107. Europe Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (MT)
 Table 108. Europe Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (MT)
 Table 109. Europe Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (MT)
 Table 110. Europe Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
 Table 111. Europe Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
 Table 112. Asia-Pacific Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (MT)
 Table 113. Asia-Pacific Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (MT)
 Table 114. Asia-Pacific Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (MT)
 Table 115. Asia-Pacific Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (MT)
 Table 116. Asia-Pacific Vaccine Adjuvants Sales Quantity by Region (2019-2024) & (MT)
 Table 117. Asia-Pacific Vaccine Adjuvants Sales Quantity by Region (2025-2030) & (MT)
 Table 118. Asia-Pacific Vaccine Adjuvants Consumption Value by Region (2019-2024) & (USD Million)
 Table 119. Asia-Pacific Vaccine Adjuvants Consumption Value by Region (2025-2030) & (USD Million)
 Table 120. South America Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (MT)
 Table 121. South America Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (MT)
 Table 122. South America Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (MT)
 Table 123. South America Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (MT)
 Table 124. South America Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (MT)
 Table 125. South America Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (MT)
 Table 126. South America Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
 Table 127. South America Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
 Table 128. Middle East & Africa Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (MT)
 Table 129. Middle East & Africa Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (MT)
 Table 130. Middle East & Africa Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (MT)
 Table 131. Middle East & Africa Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (MT)
 Table 132. Middle East & Africa Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (MT)
 Table 133. Middle East & Africa Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (MT)
 Table 134. Middle East & Africa Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
 Table 135. Middle East & Africa Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
 Table 136. Vaccine Adjuvants Raw Material
 Table 137. Key Manufacturers of Vaccine Adjuvants Raw Materials
 Table 138. Vaccine Adjuvants Typical Distributors
 Table 139. Vaccine Adjuvants Typical Customers


List of Figures
 Figure 1. Vaccine Adjuvants Picture
 Figure 2. Global Vaccine Adjuvants Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Vaccine Adjuvants Revenue Market Share by Type in 2023
 Figure 4. Emulsion Adjuvants Examples
 Figure 5. Mineral Adjuvants Examples
 Figure 6. Others Examples
 Figure 7. Global Vaccine Adjuvants Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 8. Global Vaccine Adjuvants Revenue Market Share by Application in 2023
 Figure 9. Human Vaccine Examples
 Figure 10. Veterinary Vaccine Examples
 Figure 11. Global Vaccine Adjuvants Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 12. Global Vaccine Adjuvants Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 13. Global Vaccine Adjuvants Sales Quantity (2019-2030) & (MT)
 Figure 14. Global Vaccine Adjuvants Price (2019-2030) & (USD/Kg)
 Figure 15. Global Vaccine Adjuvants Sales Quantity Market Share by Manufacturer in 2023
 Figure 16. Global Vaccine Adjuvants Revenue Market Share by Manufacturer in 2023
 Figure 17. Producer Shipments of Vaccine Adjuvants by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 18. Top 3 Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2023
 Figure 19. Top 6 Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2023
 Figure 20. Global Vaccine Adjuvants Sales Quantity Market Share by Region (2019-2030)
 Figure 21. Global Vaccine Adjuvants Consumption Value Market Share by Region (2019-2030)
 Figure 22. North America Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 23. Europe Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 24. Asia-Pacific Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 25. South America Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 26. Middle East & Africa Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 27. Global Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
 Figure 28. Global Vaccine Adjuvants Consumption Value Market Share by Type (2019-2030)
 Figure 29. Global Vaccine Adjuvants Average Price by Type (2019-2030) & (USD/Kg)
 Figure 30. Global Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
 Figure 31. Global Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
 Figure 32. Global Vaccine Adjuvants Average Price by Application (2019-2030) & (USD/Kg)
 Figure 33. North America Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
 Figure 34. North America Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
 Figure 35. North America Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
 Figure 36. North America Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
 Figure 37. United States Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 38. Canada Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 39. Mexico Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 40. Europe Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
 Figure 41. Europe Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
 Figure 42. Europe Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
 Figure 43. Europe Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
 Figure 44. Germany Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 45. France Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 46. United Kingdom Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 47. Russia Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 48. Italy Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 49. Asia-Pacific Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
 Figure 50. Asia-Pacific Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
 Figure 51. Asia-Pacific Vaccine Adjuvants Sales Quantity Market Share by Region (2019-2030)
 Figure 52. Asia-Pacific Vaccine Adjuvants Consumption Value Market Share by Region (2019-2030)
 Figure 53. China Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 54. Japan Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 55. South Korea Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 56. India Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 57. Southeast Asia Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 58. Australia Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 59. South America Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
 Figure 60. South America Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
 Figure 61. South America Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
 Figure 62. South America Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
 Figure 63. Brazil Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 64. Argentina Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 65. Middle East & Africa Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
 Figure 66. Middle East & Africa Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
 Figure 67. Middle East & Africa Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
 Figure 68. Middle East & Africa Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
 Figure 69. Turkey Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 70. Egypt Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 71. Saudi Arabia Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 72. South Africa Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
 Figure 73. Vaccine Adjuvants Market Drivers
 Figure 74. Vaccine Adjuvants Market Restraints
 Figure 75. Vaccine Adjuvants Market Trends
 Figure 76. Porters Five Forces Analysis
 Figure 77. Manufacturing Cost Structure Analysis of Vaccine Adjuvants in 2023
 Figure 78. Manufacturing Process Analysis of Vaccine Adjuvants
 Figure 79. Vaccine Adjuvants Industrial Chain
 Figure 80. Sales Channel: Direct to End-User vs Distributors
 Figure 81. Direct Channel Pros & Cons
 Figure 82. Indirect Channel Pros & Cons
 Figure 83. Methodology
 Figure 84. Research Process and Data Source

Companies Mentioned

GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio
SDA BIO
SPI Pharma
Phibro Animal Health
Vertellus